Dr Gauthier’s particular clinical research interests are in clinical trial design and the longitudinal study of clinical progression of MS. Specifically, she is interested in the application of improved statistical methods to predict disease progression and response to treatment. She has also been actively involved in numerous clinical trials, including phase I, II, and III trials, using novel therapies for the treatment of MS.